Hepatocellular carcinoma: the diagnostic difficulties of ultrasonography and analysis of risk factors in MHTS.
Thirty-nine cases of hepatocellular carcinoma (HCC) out of 55,135 examinees were examined. The diagnostic problems of ultrasonography (US) in detecting HCC and the risk value of 10 factors in HCC were discussed. We also propose the surveillance programs for HCC in Multiphasic Health Testing and Services (MHTS). US will be performed at 3-, or 6 monthly intervals in conjunction with AFP monitoring for the examinees over 50 males and over seventy females with liver dysfunction (GOT > 38 IU/ml) is recommended.
Sekiguchi
R
R
PL Tokyo Health Control Center, Japan.
Kuwajima
A
A
Nagamoto
M
M
Ohno
H
H
Tamura
M
M
D000328:Adult; D000368:Aged; D014408:Biomarkers, Tumor / Q000097:blood; D006528:Carcinoma, Hepatocellular / Q000097:blood / Q000000981:diagnostic imaging* / Q000517:prevention & control; D003937:Diagnosis, Differential; D005260:Female; D006391:Hemangioma / Q000097:blood / Q000000981:diagnostic imaging / Q000517:prevention & control; D006801:Humans; D007091:Image Processing, Computer-Assisted / Q000295:instrumentation*; D007564:Japan; D008111:Liver Function Tests; D008113:Liver Neoplasms / Q000097:blood / Q000000981:diagnostic imaging* / Q000517:prevention & control; D008297:Male; D008875:Middle Aged; D009098:Multiphasic Screening / Q000295:instrumentation; D012307:Risk Factors; D014463:Ultrasonography / Q000295:instrumentation*; D000509:alpha-Fetoproteins / Q000378:metabolism
D014408:Biomarkers, Tumor; D000509:alpha-Fetoproteins